Association of the 677c→T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects

Journal of Child Neurology

Volumn 14, Issue 3, 1999, Pages 159-161

  Boduroǧlu, Koray ^a   Alikaşifoǧlu, Mehmet ^a   Anar, Burcu ^a   Tunçbilek, Ergul ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE;

ADOLESCENT; ALLELE; ARTICLE; CHILD; DIET SUPPLEMENTATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL INHERITANCE; NEURAL TUBE DEFECT; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; TURKEY (REPUBLIC); ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE; INFANT; METABOLISM; MUTATION; NEWBORN;

ADULT; ALLELES; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HOMOCYSTEINE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; NEURAL TUBE DEFECTS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; TURKEY;

EID: 0032587430     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901400305     Document Type: Article

References (16)

1. Ou CY, Stevenson RF, Brown VK, et al: C677T homozygosity associated with theimolabile 5,10-methylenetetrahydrofolate reductase as a risk factor for neural tube defects?, abstract. Am J Hum Gene 1995;57(Suppl):A223.
2. Whitehead AS, Gallagher P, Mills JL, et al: A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995;88:763-766.
3. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, et al: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1071.
4. Posey DL, Khoury MJ, Mulinare J, et al: Is mutated MTHFR a risk factor for neural tube defects? Lancet 1996;347:686-687.
5. Papapetrou C, Lynch SA, Burn J, Edwards YJ: Methylenetetrahydrofolate reductase and neural tube defects. Lancet 1996; 348:58.
6. de Franchis R, Mandato C, Buoninconti A, et al: Neural tube defects (NTD): Investigation of genetic factors involved in homocysteine metabolism, abstract. Med Genetik 1997;9(Suppl):32.
7. Mornet E, Muller F, Lenvoise-Furet A, et al: Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 1997;100: 512-514.
8. Frosst P, Blom HJ, Milos R, et al: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
9. Medical Research Council Vitamin Study Research Group: Prevention of neural tube defects: Results of the Medical Research Council vitamin study. Lancet 1991;338:131-137.
10. Czeizel AE, Dudas I: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835.
11. Steegers-Theunissen RP, Boers GH, Trybels FJM, et al: Neural tube defects and derangement of homocysteine metabolism. N Engl J Med 1991;324:199-200.
12. Engbersen AM, Franken DG, Boers GH, et al: Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142-150.
13. Van der Put NM, Gabreels F, Stevens EM, et al: A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-1051.
14. Centers for Disease Control: Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR CDC Surveill. Summ 1992;41:1-7.
15. Clark NAC, Fisk NM: Compliance with the Department of Health recommendations: Routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynaecol 1994;101:709-710.
16. Hurren C, Thorpe L, Veltman M, et al: Folic acid and prevention of neural-tube defects. Lancet 1997;350:664.